Divi’s Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?

February 4, 2025

Divi’s Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential.

More To Explore

25% US tariff not a structural threat to Indian market: Vikas Khemani

Vikas Khemani of Carnelian Asset Management suggests that while U.S. tariffs may cause short-term earnings uncertainty for Indian exporters, a major structural risk to the

July 31, 2025

Which sectors will need a relook in terms of earnings projection now? Gautam Duggad explains

Gautam Duggad suggests that Indian stock markets are reacting steadily to tariff impacts, with financials and IT remaining stable. Earnings growth will be driven by

July 31, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003